跳至主要内容
临床试验/CTRI/2020/09/027878
CTRI/2020/09/027878尚未招募未知

â??An open-label,randomized, comparative, parallel group clinical study to evaluate the efficacy of paushkaradi kashaya and amruthadi kashaya in tamaka swasa w.s.r to bronchial asthmaâ??

Dr Abhijith0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subject with classical signs & symptoms of Tamaka swasa w.s.r to Bronchial Asthma.
  • 2.Diagnosed cases of Bronchial Asthma
  • 3.Subjects who are willing to participate in the study.
  • 4.Subjects who were ready to give informed consent for the research study

排除标准

  • 1.Subject suffering from COPD, TB, ILD, Pneumonia, Pulmonary embolism like complicated respiratory conditions.
  • 2.Emergency conditions like Status asthmatics, acute chest infections, cardiac asthma, and acute respiratory distress syndrome.
  • 3.Subject suffering from any systemic diseases like cardio vascular disorders, chronic kidney disease, carcinoma, cerebrovascular diseases, and chronic autoimmune diseases.
  • 4.Pregnant and lactating women.
  • 5.Psychiatric patients.
  • 6.Diseases which interfere with the course of disease and treatment will be excluded.

研究者

发起方
Dr Abhijith

相似试验

已完成
3 期
Clinical trial to evaluate the efficacy and safety of the fixed dose combination of Tramadol 50 mg IR + Diclofenac 75 mg SR vs fixed dose combination of Tramadol 37.5 mg + Paracetamol 325 mg in treatment of patients with moderate to severe pain due to acute musculoskeletal conditions , acute flare of osteoarthritis , acute flare of rheumatoid arthritis and post operative pai
CTRI/2011/091/000150Abbott Healthcare Private Limited, Mumbai200
已完成
4 期
Study to examine the body response of Peg-filgrastim against Neulasta® along with Chemical agent in Patients with Breast Cancer who will be selected in any order to a known treatment.
CTRI/2018/02/011914upin Limited Biotechnology Division138
已完成
不适用
A randomized, open-labelled, parallel, comparative study of the efficacy and tolerability of rosuvastatin in low-density lipoprotein-cholestrol reduction using different dosing regimens of 5 mg daily, 10 mg daily and 10 mg on alternate days in Hong Kong Chinese type 2 diabetic patientsDyslipidaemiaCirculatory System
ISRCTN72526711Chinese University of Hong Kong120
尚未招募
3 期
A clinical trial to study the efficacy and safety of Budesonide Dry Powder Inhaler Rotacaps in Patients with Mild to Moderate Asthma.
CTRI/2011/06/001788Inventia Healthcare Private Limited20
已完成
4 期
A study to evaluate the efficacy and safety of 3 study drugs in treatment of patients with with any type of eczematous disorderassociated with underlying tinea / yeast infectio
CTRI/2012/09/003000Abbott Healthcare Pvt Ltd54